|
顯示項目 576271-576280 / 2348638 (共234864頁)
<< < 57623 57624 57625 57626 57627 57628 57629 57630 57631 57632 > >>
每頁顯示[10|25|50]項目
| 臺北醫學大學 |
2008-02 |
Mesyrel® / 美舒鬱®錠
|
藥劑部 |
| 元培科技大學 |
2008-09-30 |
MES之路
|
黃志誠 |
| 元智大學 |
2014 |
MES系統導入成效探討-以A公司為例
|
鄧智偉; Chi-Wei Teng |
| 中國醫藥大學 |
2011-08-01 |
MET /AKT基因對臉部情緒知覺之影響
|
林明燈 |
| 國家衛生研究院 |
2007-12 |
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
|
Bean, J;Brennan, C;Shih, JY;Riely, G;Viale, A;Wang, L;Chitale, D;Motoi, N;Szoke, J;Broderick, S;Balak, M;Chang, WC;Yu, CJ;Gazdar, A;Pass, H;Rusch, V;Gerald, W;Huang, SF;Yang, PC;Miller, V;Ladanyi, M;Yang, CH;Pao, W |
| 國立臺灣大學 |
2007 |
Met Amplification Occurs with or without T790m Mutations in Egfr Mutant Lung Tumors with Acquired Resistance to Gefitinib or Erlotinib
|
施金元; 張文誠; 余忠仁; 黃秀芬; 楊泮池; 楊志新; SHIH, JIN-YUAN; CHANG, WEN-CHENG; YU, CHONG-JEN; HUANG, SHIU-FENG; YANG, PAN-CHYR; YANG, CHIH-HSIN |
| 臺大學術典藏 |
2018-09-10T06:32:51Z |
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
|
PAN-CHYR YANG; JIN-YUAN SHIHet al.; CHONG-JEN YU; Bean, J.; Brennan, C.; Shih, J.-Y.; Riely, G.; Viale, A.; Wang, L.; Chitale, D.; Motoi, N.; Szoke, J.; Broderick, S.; Balak, M.; Chang, W.-C.; Yu, C.-J.; Gazdar, A.; Pass, H.; Rusch, V.; Gerald, W.; Huang, S.-F.; Yang, P.-C.; Miller, V.; Ladanyi, M.; Yang, C.-H.; Pao, W. |
| 臺大學術典藏 |
2020-05-26T09:27:24Z |
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
|
Bean J;Brennan C;Shih J.-Y;Riely G;Viale A;Wang L;Chitale D;Motoi N;Szoke J;Broderick S;Balak M;Chang W.-C;Yu C.-J;Gazdar A;Pass H;Rusch V;Gerald W;Huang S.-F;Yang P.-C;Miller V;Ladanyi M;Chih-Hsin Yang;Pao W.; Bean J; Brennan C; Shih J.-Y; Riely G; Viale A; Wang L; Chitale D; Motoi N; Szoke J; Broderick S; Balak M; Chang W.-C; Yu C.-J; Gazdar A; Pass H; Rusch V; Gerald W; Huang S.-F; Yang P.-C; Miller V; Ladanyi M; CHIH-HSIN YANG; Pao W. |
| 臺大學術典藏 |
2020-08-13T06:34:03Z |
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
|
Bean J.; Brennan C.; JIN-YUAN SHIH; Riely G.; Viale A.; Wang L.; Chitale D.; Motoi N.; Szoke J.; Broderick S.; Balak M.; Chang W.-C.; Yu C.-J.; Gazdar A.; Pass H.; Rusch V.; Gerald W.; Huang S.-F.; Yang P.-C.; Miller V.; Ladanyi M.; Yang C.-H.; Pao W.; Bean J.;Brennan C.;Jin-Yuan Shih;Riely G.;Viale A.;Wang L.;Chitale D.;Motoi N.;Szoke J.;Broderick S.;Balak M.;Chang W.-C.;Yu C.-J.;Gazdar A.;Pass H.;Rusch V.;Gerald W.;Huang S.-F.;Yang P.-C.;Miller V.;Ladanyi M.;Yang C.-H.;Pao W. |
| 臺大學術典藏 |
2022-06-27T07:06:29Z |
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
|
Bean J.; Brennan C.; Shih J.-Y.; Riely G.; Viale A.; Wang L.; Chitale D.; Motoi N.; Szoke J.; Broderick S.; Balak M.; Chang W.-C.; CHONG-JEN YU; Gazdar A.; Pass H.; Rusch V.; Gerald W.; Huang S.-F.; Yang P.-C.; Miller V.; Ladanyi M.; Yang C.-H.; Pao W. |
顯示項目 576271-576280 / 2348638 (共234864頁)
<< < 57623 57624 57625 57626 57627 57628 57629 57630 57631 57632 > >>
每頁顯示[10|25|50]項目
|
